The aim of the present study was to evaluate the effects of yerba maté extract upon markers of insulin resistance and inflammatory markers in mice with high fat diet-induced obesity. The mice were introduced to either standard or high fat diets. After 12 weeks on a high fat diet, mice were randomly assigned to one of the two treatment conditions, water or yerba maté extract at 1.0 g kg −1 . After treatment, glucose blood level and hepatic and soleus muscle insulin response were evaluated. Serum levels of TNF-␣ and IL-6 were evaluated by ELISA, liver tissue was examined to determine the mRNA levels of TNF-˛, IL-6 and iNOS, and the nuclear translocation of NF-B was determined by an electrophoretic mobility shift assay. Our data show improvements in both the basal glucose blood levels and in the response to insulin administration in the treated animals. The molecular analysis of insulin signalling revealed a restoration of hepatic and muscle insulin substrate receptor (IRS)-1 and AKT phosphorylation. Our data show that the high fat diet caused an up-regulation of the TNF-˛, IL-6, and iNOS genes. Although after intervention with yerba maté extract the expression levels of those genes returned to baseline through the NF-B pathway, these results could also be secondary to the weight loss observed. In conclusion, our results indicate that yerba maté has a potential anti-inflammatory effect. Additionally, these data demonstrate that yerba maté inhibits hepatic and muscle TNF-␣ and restores hepatic insulin signalling in mice with high fat diet-induced obesity.
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Introduction
The high prevalence of obesity is a major threat to public health due to the causal role it plays in the predisposition to complications such as atherosclerosis, hepatic steatosis, and type 2 diabetes (Berg and Scherer, 2005) . Such conditions are closely associated with chronic inflammation, characterised by abnormal cytokine production, increased acute-phase reactants and other mediators, and activation of a network of inflammatory signalling pathways (Wellen and Hotamisligil, 2005) . There is growing evidence that a large component of obesity-associated pathophysiology may stem from a low-grade pro-inflammatory state. The manifestation of this pro-inflammatory state includes increased production of pro-inflammatory molecules, such as TNF-␣, monocyte chemoat-tractant protein 1 (MCP-1), interleukin-6 (IL-6), inducible nitric oxide synthase (iNOS), and plasminogen activator inhibitor-1 (PAI-1) in liver, adipose, and muscle tissue. An increased activation of inflammatory signalling pathways, such as the nuclear factor-B pathway, is also involved (NF-B) (Weisberg et al., 2003; Cinti et al., 2005) .
The cytokine gene expression is initiated following the activation of the NF-B signal transduction pathway, which is mediated by TNF-␣ (Andreakos et al., 2005) . NF-B itself is a heterodimeric transcription factor that is retained in the cytosol in its inactive state as a complex with a set of inhibitory proteins designated IB. Upon activation of NF-B signalling, the IB complex is phosphorylated by IB kinase-␤ (IKK␤). Free NF-B is then able to translocate to the nucleus where it binds to specific promoter elements resulting in the activation of several genes, including those for inflammatory proteins (Andreakos et al., 2005) . Additionally, activation of the TNF receptor results in serine phosphorylation of insulin receptor substrates (IRSs) via Ikk␤, which attenuates its ability to transduce insulin-mediated cellular events (Hotamisligil, 2006) .
Insulin is the most potent anabolic hormone known and is essential for appropriate tissue development, growth, and the maintenance of whole-body glucose homeostasis. Insulin resistance occurs when normal circulating concentrations of the hormone are insufficient to regulate these processes appropriately (Pessin and Saltiel, 2000) . In the presence of insulin, the insulin receptor autophosphorylates and catalyses several intracellular substrates, including IRS proteins (Taniguchi et al., 2006) . These substrates are involved in the activation of two main signalling pathways: the phosphatidylinositol 3-kinase (PI3K) protein kinase B/Akt pathway, which is responsible for most of the metabolic actions of insulin, and the Ras-mitogen-activated protein kinase (MAPK) pathway, which regulates the expression of some genes and participates in glucose transport (González-Yanes et al., 2005) .
It has been reported that natural products may improve glucose metabolism and insulin action (Broadhurst et al., 2000) . Yerba maté (Ilex paraguariensis), one of the most widely consumed plants in South America, has been shown to have some beneficial effects on glucose absorption and on metabolism (Oliveira et al., 2008) . Additionally, maté beverages have been reported to have various biological activities, which have been attributed to its high polyphenol content. Along with polyphenols, such as flavonoids (quercetin and rutin) and phenolic acids (chlorogenic and caffeic acids), yerba maté is also rich in caffeine and saponins (Bastos et al., 2007) . Recently published evidence has shown some beneficial effects of I. paraguariensis, including antioxidant activity (Miranda et al., 2008) , a protective effect against induced DNA damage (Miranda et al., 2008) , vasodilatation effects (Stein et al., 2005) , inhibition of glycation and atherosclerosis (Mosimann et al., 2006) , thermogenic effects (Pomilio et al., 2002) , and anti-obesity effects (Arç ari et al., 2009) .
Based on previous data showing that yerba maté extract has potent anti-obesity activity and a modulatory effect on the expression of several genes related to obesity in white adipose tissue in vivo (Arç ari et al., 2009) , the aim of the present study was to evaluate the effects of yerba maté extract upon markers of insulin resistance and inflammatory markers in mice with high fat diet-induced obesity.
Materials and methods

Maté tea preparation
The roasted yerba maté extract was prepared by dissolving lyophilised instant maté tea (Leao Jr, Curitiba-PR, Brazil) in water using a homogeniser and was prepared fresh each day. The aqueous maté tea and vehicle (pure water) were administered by intragastric gavage. The extract contained 348.80 ± 16.35 mg/g of phenolic compounds, 5.82 ± 0.17 mg/g of caffeine, 32.25 ± 0.50 mg/g of 5-caffeyolquinic acid, 0.58 ± 0.01 mg/g of caffeic acid, and 3.30 ± 0.35 mg/g of theobromine (Arç ari et al., 2009).
Animals and diets
Thirty 6-week-old male Swiss strain mice (Sw/Uni) (27.3 ± 0.4 g) free of specific pathogens were obtained from CEMIB (State University of Campinas, Campinas, SP, Brazil). The experiments were performed in accordance with the principles outlined by the Brazilian College for Animal Experimentation (COBEA) and received approval from the Ethics Committee of São Francisco University, Braganç a Paulista, SP, Brazil. The animals were maintained on a 12 h:12 h artificial light:dark cycle and housed in individual cages.
After random selection, mice were introduced to either standard (SD, n = 10) or high fat diets (HFD, n = 20) for sixteen weeks. The compositions of experimental diets are shown in Table 1 . After the first eight weeks on a high fat diet, the obesity status was observed, and the animals were randomly divided into two treatment subgroups. The first group (HFD + Mt, n = 10) received an aqueous extract of roasted yerba maté extract (1.0 mg kg −1 ), and the other group received the vehicle (HFD, n = 10) for eight weeks. The compositions of the experimental diets have been described previously (Arç ari et al., 2009) . At the end of sixteen weeks, mice were anaesthetised with 1 l/g of body weigh (1:1 xylazine 2%-ketamine 10%) and blood samples were collected from the heart. Transcardiac perfusion with 70 ml isotonic saline solution (4
• C) was then carried out over a period of 6 min. 
Blood glucose levels and insulin tolerance test
After 6 h of fasting, mice were anesthetised with an intraperitoneal 4 l/g injection of xylasine/ketamine of body weigh (1:1 xylazine 2%-ketamine 10%), and blood samples were collected from the tail. Glucose was measured using the glucose oxidase method. Insulin (1.5 U/kg) was administered by i.p. injection, and blood samples were collected at 0, 10, 15, 20, and 30 min for serum glucose determination. The rate constant for glucose disappearance during an insulin tolerance test (KITT) was calculated using the formula 0.693/t 1/2 . The glucose t 1/2 was calculated from the slope of the least-square analysis of the plasma glucose concentrations during the linear decay phase (Bonora et al., 1987) .
RNA extraction and quantitative real-time PCR
Liver and interscapular brown adipose tissue (BAT) fragments were collected, snap frozen, and stored at −80
• C in RNAlater (QIAGEN, Valencia, CA, USA). Total RNA was isolated using the RNeasy ® tissue kit (QIAGEN). The single-stranded cDNA was synthesised using the High Capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA, USA) following the manufacturer's protocol. Quantitative PCR was performed using a 7300 Real-Time PCR System (Applied Biosystems, Foster City, CA, USA), and threshold cycle numbers were determined using RQ Study Software (Applied Biosystems). Reactions were performed in triplicate, and the threshold cycle numbers were averaged. The 50-l reaction mixture was prepared as follows: 25 l of Platinum ® SYBR Green Quantitative PCR SuperMix-UDG (Invitrogen TM Life Technologies, Alemeda, CA, USA), 10 M of each primer (Table 2 ) and 10 l of cDNA (100 ng). The reaction was cycled with preliminary UDG treatment for 2 min at 50
• C and denatured for 2 min at 95
• C, followed by 45 cycles of denaturation at 95
• C for 15 s, annealing for 15 s, and primer extension at 72
• C for 15 s. This was followed by a melting point analysis of the double-stranded amplicons consisting of 40 cycles with a 1
• C decrement (15 s each) beginning at 95
• C. The first derivative of this plot, dF/dT, is the rate of change of fluorescence in the reaction. A significant change in fluorescence accompanies the melting curve of the double-stranded PCR products. A plot of -dF/dT vs. temperature displays these changes as distinct peaks. The liver expression of TNF-˛, IL-6 and iNOS, and the BAT mRNA levels of UCP-1 and PGC-1␣ were examined and normalised to a constitutive gene (␤-actin), and the relative fold induction was calculated according to the formula 2 (− Ct) (Livak and Schmittgen, 2001) . 
Protein extraction and western immunoblot analysis
Liver and soleus muscle fragments were excised and immediately homogenised in a solubilising buffer [1% Triton X-100, 100 mM Tris-HCl (pH 7.4), 100 mM sodium pyrophosphate, 100 mM sodium fluoride, 10 mM EDTA, 10 mM sodium orthovanadate, 2.0 mM PMSF, and 0.1 mg aprotinin/ml] at 4
• C. Insoluble material was removed by centrifugation for 20 min at 9000 × g at 4
• C. The protein concentration of the supernatants was determined using the Biuret method. The extracts were treated with Laemmli sample buffer containing 100 mM dithiothreitol, heated in a boiling water bath for 5 min, and subjected to SDS-PAGE in a Bio-Rad miniature slab gel apparatus (Mini-Protean). For immunoblot experiments, 0.15 mg of protein extract from each tissue was separated by SDS-PAGE, transferred to nitrocellulose membranes, and blotted with anti-IRS-1, anti-p-IRS-1/2, anti-AKT or anti-p-AKT. The nitrocellulose membranes were developed using commercial chemiluminescent kits. Band intensities were quantified by optical densitometry (Scion Image software, ScionCorp, Frederick, MD, USA) of the developed autoradiography.
Electrophoretic mobility shift assay (EMSA)
Liver fragments were excised, and the nuclear and cytoplasmic proteins were extracted immediately using the NE-PER-Nuclear and Cytoplasmic Extraction Reagent Kit (Pierce Protein Research Product, Rockford, IL, USA) following the manufacturer's protocol. Binding of NFB was assessed in nuclear extracts by an electrophoretic mobility-shift assay (EMSA). Double-stranded oligonucleotides for NF-B (Promega, Madison, WI, USA) were labelled on the 3 end with biotin by using the 3 -Biotin end-label kit from Pierce. EMSA was carried out by using the Lightshift kit from Pierce. Briefly, binding reactions containing 10 g of nuclear protein, 10 mM Tris, 50 mM KCl, 1 mM DTT, 2.5% glycerol, 5 mM MgCl2, 0.05% Nonidet P-40, and 2 pmol of oligonucleotide probe were incubated for 20 min at room temperature. Specific binding was confirmed by using a 100-400-fold excess of unlabeled probe as the specific competitor. Protein DNA complexes were separated by 6% non-denaturing acrylamide gel electrophoresis. Complexes were transferred to positively charged nylon membranes and UV-crosslinked. Gel shifts were visualised with a streptavidin-horseradish peroxidase followed by chemiluminescent detection.
Statistical analysis
Data are expressed as the mean ± S.E.M. Comparisons among groups of data were performed using one-way ANOVA followed by the Dunnett's Multiple Comparisons test. Statistical significance for expression analysis was also assessed by ANOVA, and the differences identified were pinpointed by the unpaired Student's ttest. An associated probability (P value) of less than 5% was considered as significant (p < 0.05).
Results
Glucose blood level and insulin response
Consumption of the HFD induced a significant weight gain, but after eight weeks of yerba maté intervention, we observed a reduction in final body weight. This weight loss was not related to a reduction in food intake (Table 3) .
After 16 weeks of HFD consumption, the mice presented an increase of glucose blood level and insulin resistance, as determined by the constant of glucose decay during an insulin tolerance test. After yerba maté treatment, the blood glucose level was similar to that observed in control animals, and the response to insulin administration was improved (Table 3 ). This functional response was confirmed by hepatic analysis of insulin signalling. After 30 s of insulin administration, the level of hepatic IRS-1-and AKTphosphorylation observed in animals that received yerba maté was significantly increased as compared with non-treated HFD animals ( Fig. 1A and B) . Similar results were observed by soleus muscle analysis of insulin signalling. After 90 s of insulin administration, the level of IRS-1-and AKT-phosphorylation observed in animals that received yerba maté was significantly increased as compared with non-treated HFD animals ( Fig. 1C and D) . 
Yerba maté increases the expression of genes involved in thermogenesis
Quantitative real time PCR analysis was performed to evaluate the expression of PGC-1˛, and UCP2 in interscapular brown adipose tissue. In BAT, the HFD significantly down regulated the expression of UCP1 and PGC-1˛. The yerba maté intervention recovered the expression of the genes implicated in thermogenesis in BAT (Table 3) .
Yerba maté modulates inflammatory markers through the NF-ÄB pathway
The mRNA expression levels of TNF-˛, IL-6, and iNOS were determined by means of real time PCR using isolated liver tissue from each group of animals. Our data showed that the HFD caused an up-regulation of the TNF-˛, IL-6 and iNOS genes. After treatment with yerba maté extract, the expression levels of those genes were significantly reduced. On the other hand, yerba maté did not change the serum levels of TNF-␣ and IL-6 (Table 3) .
To evaluate the nuclear translocation of NF-B, nuclear extracts were subjected to EMSA using a NF-B consensus sequence (Fig. 2) . The NF-B-derived band was barely visible in the SD group, and as expected, it was strongly enhanced in animals fed with the HFD for 16 weeks. Yerba maté extract was able to reduce the nuclear translocation of NF-B. The specificity of this band was confirmed by the addition of 100-fold excess of the unlabelled probe (data not shown). Thus, the treatment with yerba maté extract significantly down-regulated the inflammatory gene response, possibly through a decrease on the activation of NF-B.
Discussion
Previously, we demonstrated that treatment with yerba maté extract has potent anti-obesity effects in adipose tissue in vivo by modulating the expression of several genes related to obesity processes, such as inflammatory markers (Arç ari et al., 2009) . Because the increase in adipokine production can influence glucose metabolism, insulin sensitivity, and inflammation, this finding could represent a molecular link between obesity and the development of diabetes mellitus, metabolic syndromes, and cardiovascular diseases (Shimomura et al., 1999) . We studied the putative effects of yerba maté extract on blood glucose levels, insulin resistance, and the regulation of gene expression of inflammatory markers in mice with high fat diet-induced obesity.
Our data demonstrated that obese mice when treated with yerba maté exhibited marked attenuation of weight gain adiposity with- out a reduction on food intake. Therefore, it was evaluated the effect of yerba maté treatment on mRNA levels of genes involved whole body energy expenditure such as PGC-1˛ (Argilés et al., 2002) and UCP1 (Lowell and Spiegelman, 2000) . Our data showed that a high fat diet down regulates the expression of PGC-1˛and UCP1 in BAT, which may have decreased energy expenditure and increased diet-induced obesity (Argyropoulos and Harper, 2002) . The present study also showed that PGC-1˛and UCP1 mRNA levels in BAT were recovered after yerba maté treatment, as previously described (Arç ari et al., 2009) .
In the present study, blood glucose homeostasis was evaluated, and a significant decrease in fasting blood glucose was observed, along with an increase in the K ITT value. In addition, insulin IRS/AKT phosphorylation was measured in the liver and in muscle, and an improvement in signalling was detected. In accordance with our data, it has been shown that yerba maté treatment improves glucose tolerance in obese animals (Pomilio et al., 2002; Rodriguez de Sotillo and Hadley, 2002) . It has been suggested that this effect could be attributed to chlorogenic acid, the main polyphenol in yerba maté. Chlorogenic acid is thought to modulate the activity of glucose-6-phosphatase, which is involved in glucose metabolism (Hemmerle et al., 1997) .
Insulin resistance is a central feature of many physiological and pathological states and can be the result of a wide variety of biochemical defects in the insulin action cascade (Virkamäki et al., 1999) . It is known that TNF-␣, a major pro-inflammatory factor, mediates insulin resistance through multiple targets: (i) activation of the insulin receptor via stimulation of phosphorylation of serine residues of IRS-1 (Hotamisligil et al., 1996) , which negatively regulates insulin receptor tyrosine phosphorylation, blunts the insulin-stimulated tyrosine phosphorylation of IRS-1 (Ozes et al., 2001) , and inhibits glucose uptake (del Aguila et al., 1999) ; and (ii) activation of the NF-B pathway (Hotamisligil et al., 1993) .
Our data showed that obesity led to an increase of serum and liver mRNA levels of TNF-␣. Adipose tissue is an important source of TNF-␣ in obesity (Arç ari et al., 2009) . Additionally, free fatty acids that are provided by adipose tissue to the liver increase both hepatic insulin resistance and hepatic TNF-␣ production, the latter of which contributes to insulin resistance (Diehl, 2005) . Although after the yerba maté treatment a reduction in adiposity and hepatic TNF-␣ mRNA levels was observed, we cannot exclude that the results could also be secondary to the weight loss observed. The decrease of TNF-␣ expression was correlated with an increase of IRS-1 tyrosine phosphorylation. Because tyrosine phosphorylation of the insulin receptor is crucial for activation of the downstream signalling components that lead to the metabolic effects of insulin, our data demonstrated that yerba maté treatment could result in improvements in hepatic insulin sensitivity through down-regulation of TNF-␣.
It is well known that an up-regulation of TNF-␣ leads to an increase in NF-B nuclear translocation, which results in the activation of a battery of genes. These genes include those encoding for inflammatory proteins such as IL-6 and iNOS, which play a critical role in obesity-related inflammation and metabolic pathologies (Andreakos et al., 2005; Xie et al., 1994) . Therefore, we evaluated the effects of yerba maté treatment on the nuclear translocation of NF-B. The data presented herein showed that yerba maté extract was able to reduce the nuclear translocation of NF-B in liver when compared to the HFD group. Additionally, we found that HFD caused an up-regulation of the IL-6 and iNOS genes, which were significantly reduced after yerba maté extract treatment. IL-6 is known as the major determinant of the acute phase response of inflammation (Gabay, 2006) . Because IL-6 also has effects on glucose transport and insulin action (Kern et al., 2001) , the reduction of hepatic IL-6 expression levels by yerba maté could help restore these parameters in our model. The iNOS expression in ob/ob mice was increased in the liver, and treatment with an iNOS inhibitor reversed fasting hyperglycaemia and improved insulin sensitivity by enhancing IRSs-mediated insulin signalling in the liver (Fujimoto et al., 2005) . It is believed that iNOS promotes the nitrosilation of proteins that are involved in the transduction of the insulin signal, including the insulin receptor, IRSs and AKT, and that this process contributes to the reduction in insulin sensitivity (Carvalho-Filho et al., 2006) . Thus, the reduction of NF-B nuclear translocation and the consequent down-regulation of IL-6 and iNOS seems to be correlated with down-regulation of TNF-˛mRNA expression, demonstrating that suppression of TNF-˛production occurs at the transcriptional level.
Conclusions
Taken together, our results indicate that yerba maté has a potential anti-inflammatory effect that is mediated through the NF-B pathway, as previously described (Puangpraphant and de Mejia, 2009 ). Additionally, these data demonstrate, for the first time, that yerba maté can inhibit hepatic TNF-␣ and restore hepatic and muscle insulin signalling in mice with high fat diet-induced obesity.
